Simponi and Botox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simponi (golimumab) and Botox (botulinum toxin type a). Common drug interactions include arthralgia among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Simponi and Botox. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Simponi?

Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.

On Jul, 07, 2026

22 people who take Simponi and Botox together, and have interactions are studied.

What are the common drug interactions of Simponi and Botox, by gender? *:

female:

Arthralgia (joint pain)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Upper respiratory tract infection
Urticaria (rash of round, red welts on the skin that itch intensely)
Drug hypersensitivity
Alopecia (absence of hair from areas of the body)
Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
Brain death
Burning sensation
Cerebral haemorrhage (bleeding within the brain)

male:

Insomnia (sleeplessness)

What are the common drug interactions of Simponi and Botox, by age (0-1 to 60+)? *:

0-1:

Drug hypersensitivity

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cubital tunnel syndrome (a condition brought on by increased pressure on the ulnar nerve at the elbow)
Drug ineffective
Procedural pain

40-49:

Alopecia (absence of hair from areas of the body)
Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
Drug hypersensitivity
Muscle spasms (muscle contraction)

50-59:

Brain death
Cerebral haemorrhage (bleeding within the brain)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)

60+:

Anaphylactic reaction (serious allergic reaction)
Arthralgia (joint pain)
Upper respiratory tract infection
Urticaria (rash of round, red welts on the skin that itch intensely)
Dizziness
Dystonia (abnormal muscle tone)
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Stress

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 12 people, 54.55%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 13.64%
Movement - Uncontrolled Or Slow: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Simponi and Botox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously